Andreas Beilhack

This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Julius-Maximilians-Universitat Wurzburg. Active years: 2019-2026.

USPTO Granted Patents = 2 (Patent Applications = 3)

% Patents Active = 50.0

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 3.4

ph-index = 1

Company Filing History:

2 out of 53

Julius-Maximilians-Universitat Wurzburg

patents

Years Active: 2019-2026

Loading Chart...

2 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12715928 - TUMOR NECROSIS FACTOR (TNF) RECEPTOR SUPERFAMILY (TNFRSF) RECEPTOR-ACTIVATING ANTIBODY FUSION PROTEINS WITH FCgR-INDEPENDENT AGONISTIC ACTIVITY (TNFRSF RECEPTOR-ACTIVATING ANTIBODY FUSION PROTEINS WITH FCgR-INDEPENDENT AGONISTIC ACTIVITY; TRAAFFIAA) (2026-08-25),

2. 10253294 - Galactose oxidase treatment of dendritic cells to improve their immunogenicity (2019-04-09),

Profile summary based on public USPTO records.